Catalyst Wire Dossier Catalyst Wire Dossier

Arginine-based oral formulation

L-Arginine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Arginine-based oral formulation, covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Arginine- and Glutamine-based Oral Formulations on Salivary Biomarkers and Clinical Severity of Radiation-induced Oral Mucositis in Head and Neck Cancer: A Randomized Controlled Trial [Phase 2]

See pricing